PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Saved in:
| Title: | PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer. |
|---|---|
| Authors: | Ren X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Cui H; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Dai L; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Chang L; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Liu D; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Yan W; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Zhao X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Kang H; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. kanghuafeng1973@126.com., Ma X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. binbinmxb@sohu.com. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Mar 11; Vol. 150 (3), pp. 119. Date of Electronic Publication: 2024 Mar 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38466449 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ren+X%22">Ren X</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Cui+H%22">Cui H</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Dai+L%22">Dai L</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Chang+L%22">Chang L</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Yan+W%22">Yan W</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Kang+H%22">Kang H</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. kanghuafeng1973@126.com.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. binbinmxb@sohu.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227902060%22">Journal of cancer research and clinical oncology</searchLink> [J Cancer Res Clin Oncol] 2024 Mar 11; Vol. 150 (3), pp. 119. <i>Date of Electronic Publication: </i>2024 Mar 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7902060 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1335 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201715216%22">01715216 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer Res Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38466449 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00432-024-05626-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 119 Titles: – TitleFull: PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ren X – PersonEntity: Name: NameFull: Cui H – PersonEntity: Name: NameFull: Dai L – PersonEntity: Name: NameFull: Chang L – PersonEntity: Name: NameFull: Liu D – PersonEntity: Name: NameFull: Yan W – PersonEntity: Name: NameFull: Zhao X – PersonEntity: Name: NameFull: Kang H – PersonEntity: Name: NameFull: Ma X IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 03 Text: 2024 Mar 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1432-1335 Numbering: – Type: volume Value: 150 – Type: issue Value: 3 Titles: – TitleFull: Journal of cancer research and clinical oncology Type: main |
| ResultId | 1 |
